14.96 USD
↘ 0.83 (5.24%)LIVE (AS OF 01:31 PM EDT)
Personalis, Inc. Common Stock
PSNLNASDAQ • USD
Market: OPEN
Shares of Personalis, Inc. Common Stock (PSNL) are trading at $14.96. PSNL shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jul 15, 2026.
Open?$15.50
High?$16.12
Low?$14.84
Prev. Close?$15.79
Volume?2.5M
Avg. Volume?4.1M
VWAP?$15.18
Rel. Volume?0.62x
Bid / Ask
Bid?$14.91 × 100
Ask?$14.94 × 100
Spread?$0.03
Midpoint?$14.93
Valuation & Ratios
Market Cap?1.7B
Shares Out?104.7M
Float?59.5M
Float %?56.8%
P/E Ratio?N/A
P/B Ratio?6.49
EPS?-$0.91
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Themes
Employees
260
Market Cap
1.7B
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2019-06-20
Address
6600 DUMBARTON CIRCLE
FREMONT, CA 94555
Phone: 650-752-1300
FREMONT, CA 94555
Phone: 650-752-1300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?2
Short Sent.?57
Piotroski F-Score?0/9Weak
Altman Z-Score?20.26Safe
Confidence?51%Low
Short InterestHigh
Short % of Float?19.02%High
Short Interest?11.3M
Days to Cover?2.8
Free Float59.5M
Avg Daily Volume4.1M
Settlement Date2026-06-30
Financial Health
Current Ratio?6.61Strong
Quick Ratio?6.44Strong
Cash Ratio?1.88Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?6.49FAIR▾
Peers100
S&P29
P/S?25.63HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-17.1CHEAP▾
S&P97
EV/Sales?24.49HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-37.5%WEAK▾
S&P3
ROA?-29.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-84648000
Enterprise Value?$1.6B
Fundamentals ratios updated end of day